Similar acute molecular responses to equivalent volumes of isometric, lengthening, or shortening mode resistance exercise

Journal of Applied Physiology

Volumn 102, Issue 1, 2007, Pages 135-143

  Garma, T ^a   Kobayashi, C ^a   Haddad, F ^a   Adams, G R ^a   Bodell, P W ^a   Baldwin, K M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anabolic signaling; Concentric mode; Eccentric mode; Hypertrophy

Indexed keywords

MESSENGER RNA; MYOSTATIN; PROCOLLAGEN; PROCOLLAGEN III ALPHA1; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRIC MUSCLE CONTRACTION; CONTROLLED STUDY; ECCENTRIC MUSCLE CONTRACTION; FEMALE; ISOMETRIC EXERCISE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PHYSICAL ACTIVITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT;

ANIMALS; BODY WEIGHT; COLLAGEN TYPE III; DNA; FEMALE; INSULIN-LIKE GROWTH FACTOR I; ISOMETRIC CONTRACTION; METABOLISM; MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCLE STRETCHING EXERCISES; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; RNA; TRANSFORMING GROWTH FACTOR BETA;

EID: 33846134397     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00776.2006     Document Type: Article

References (47)

1. Adams GR, Caiozzo VJ, Haddad F, Baldwin KM. Cellular and molecular responses to increased skeletal muscle loading after irradiation. Am J Physiol Cell Physiol 283: C1182-C1195, 2002.
2. Adams GR, Cheng DC, Haddad F, Baldwin KM. Skeletal muscle hypertrophy in response to isometric, lengthening and shortening training bouts of equivalent duration. J Appl Physiol 96: 1613-1618, 2004.
3. Adams GR, Haddad F. The relationships between IGF-1, DNA content, and protein accumulation during skeletal muscle hypertrophy. J Appl Physiol 81: 2509-2516, 1996.
4. Adams GR, Haddad F, Baldwin KM. Time course of changes in markers of myogenesis in overloaded rat skeletal muscles. J Appl Physiol 87: 1705-1712, 1999.
5. Adams GR, McCue SA. Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol 84: 1716-1722, 1998.
6. Alexander WS. Suppressors of cytokine signaling (SOCS) in the immune system. Nat Rev Immunol 2: 410-416, 2002.
7. Allen DL, Roy RR, Edgerton VR. Myonuclear domains in muscle adaptation and disease. Muscle Nerve 22: 1350-1360, 1999.
8. Bickel CS, Slade J, Mahoney E, Haddad F, Dudley GA, Adams GR. Time course of molecular responses of human skeletal muscle to acute bouts of resistance exercise. J Appl Physiol 98: 482-488, 2005.
9. Bickel CS, Slade JM, Haddad F, Adams GR, Dudley GA. Acute molecular responses of skeletal muscle to resistance exercise in able-bodied and spinal cord-injured subjects. J Appl Physiol 94: 2255-2262, 2003.
10. Booth FW, Baldwin KM. Muscle plasticity: energy demand and supply processes. In: Handbook of Physiology. Exercise: Regulation and Integration of Multiple Systems. Bethesda, MD: Am. Physiol Soc., 1996, sect. 12, chapt. 24, p. 1075-1123.
11. Caiozzo VJ, Ma E, McCue SA, Smith E, Herrick RE, Baldwin KM. A new animal model for modulating myosin expression by altered mechanical activity. J Appl Physiol 73: 1432-1440, 1992.
12. Carbia-Nagashima A, Arzt E. Intracellular proteins and mechanisms involved in the control of gp130/JAK/STAT cytokine signaling. IUBMB Life 56: 83-88, 2004.
13. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 :156 -159, 1987.
14. Colliander EB, Tesch PA. Effects of eccentric and concentric muscle actions in resistance training. Acta Physiol Scand 140: 31-39, 1990.
15. Croker BA, Krebs DL, Zhang JG, Wormald S, Willson TA, Stanley EG, Robb L, Greenhalgh CJ, Forster I, Clausen BE, Nicola NA, Metcalf D, Hilton DJ, Roberts AW, Alexander WS. SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immun 4: 540-545, 2003.
16. DeVol DL, Rotwein P, Sadow JL, Novakofski J, Bechtel PJ. Activation of insulin like growth factor gene expression during work induced skeletal muscle growth. Am J Physiol Endocrinol Metab 259: E89-E95, 1990.
17. Febbraio MA, Hiscock N, Sacchetti M, Fischer CP, Pedersen BK. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes 53: 1643-1648, 2004.
18. Flores-Morales A, Greenhalgh CJ, Norstedt G, Rico-Bautista E. Negative regulation of GH receptor signaling. Mol Endocrinol 20: 241-253, 2006. First published July 21, 2005.
19. Glass DJ. Molecular mechanisms modulating muscle mass. Trends Mol Med 9: 344-350, 2003.
20. Goldspink G. Changes in muscle mass and phenotype and the expression of autocrine and systemic growth factors by muscle in response to stretch and overload. J Anat 194: 323-334, 1999.
21. Greenhalgh CJ, Bertolino P, Asa SL, Metcalf D, Corbin JE, Adams TE, Davey HW, Nicola NA, Hilton DJ, Alexander WS. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). Mol Endocrinol 16: 1394-1406, 2002.
22. Haddad F, Adams GR. Acute cellular and molecular responses to resistance exercise. J Appl Physiol 93: 394-403, 2002.
23. Haddad F, Adams GR. Aging sensitive cellular and molecular mechanisms associated with skeletal muscle hypertrophy. J Appl Physiol 100: 1188-1203, 2006.
24. Haddad F, Adams GR, Bodell PW, Baldwin KM. Isometric resistance exercise fails to counteract skeletal muscle atrophy processes during the initial stages of unloading. J Appl Physiol 100: 433-441, 2006.
25. Haddad F, Zaldivar FP, Cooper DM, Adams GR. IL-6 induced skeletal muscle atrophy. J Appl Physiol 98: 911-917, 2005.
26. Hannan KM, Hannan RD, Rothblum LI. Transcription by RNA polymerase I. Front Biosci 3: 376-398, 1998.
27. Hather BM, Tesch PA, Buchanan P, Dudley GA. Influence of eccentric actions on skeletal muscle adaptations to resistance training. Acta Physiol Scand 143: 177-185, 1991.
28. Jones DA, Rutherford OM. Human muscle strength training: the effects of three different regimes and the nature of the resultant changes. J Physiol 391: 1-11, 1987.
29. Kraemer WJ, Adams K, Cafarelli E, Dudley GA, Dooly C, Feigenbaum MS, Fleck SJ, Franklin B, Fry AC, Hoffman JR, Newton RU, Potteiger J, Stone MH, Ratamess NA, Triplett-McBride T. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc 34: 364-380, 2002.
30. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102: 344-352, 1980.
31. Lee SJ. Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol 20: 61-86, 2004.
32. Lieskovska J, Guo D, Derman E. Growth impairment in IL-6-overexpressing transgenic mice is associated with induction of SOCS3 mRNA. Growth Horm IGF Res 13: 26-35, 2003.
33. Liu W, Thomas SG, Asa SL, Gonzalez-Cadavid N, Bhasin S, Ezzat S. Myostatin is a skeletal muscle target of growth hormone anabolic action. J Clin Endocrinol Metab 88: 5490-5496, 2003.
34. Marcell TJ, Harman SM, Urban RJ, Metz DD, Rodgers BD, Blackman MR. Comparison of GH, IGF-I, and testosterone with mRNA of receptors and myostatin in skeletal muscle in older men. Am J Physiol Endocrinol Metab 281: E1159-E1164, 2001.
35. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 387: 83-90, 1997.
36. Michaylira CZ, Simmons JG, Ramocki NM, Scull BP, McNaughton KK, Fuller CR, Lund PK. Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo. Am J Physiol Gastrointest Liver Physiol 291: G472-G481, 2006.
37. Mooney RA, Senn J, Cameron S, Inamdar N, Boivin LM, Shang Y, Furlanetto RW. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J Biol Chem 276: 25889-25893, 2001.
38. Morissey MC, Harman EA, Johnson MJ. Resistance training modes: specificity and effectiveness. Med Sci Sports Exerc 27: 648-660, 1995.
39. Nader GA, McLoughlin TJ, Esser KA. mTOR function in skeletal muscle hypertrophy: increased ribosomal RNA via cell cycle regulators. Am J Physiol Cell Physiol 289: C1457-C1465, 2005.
40. Olesen JL, Heinemeier KM, Haddad F, Langberg H, Flyvbjerg A, Kjaer M, Baldwin KM. Expression of insulin-like growth factor I, insulin-like growth factor binding proteins, and collagen mRNA in mechanically loaded plantaris tendon. J Appl Physiol 101: 183-188, 2006.
41. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3: 1009-1013, 2001.
42. Siehl D, Chua BH, Lautensack-Belser N, Morgan HE. Faster protein and ribosome synthesis in thyroxine-induced hypertrophy of rat heart. Am J Physiol Cell Physiol 248: C309-C319, 1985.
43. Solaro J, Pang DC, Briggs FN. The purification of cardiac myofibrils with Triton X-100. Biochim Biophys Acta 245: 259-262, 1971.
44. Spangenburg EE. SOCS-3 induces myoblast differentiation. J Biol Chem 280: 10749-10758, 2005.
45. Spangenburg EE, Brown DA, Johnson MS, Moore RL. Exercise increases SOCS-3 expression in skeletal muscle: potential relationship to IL-6 expression. J Physiol 572: 839-849, 2006; 10.1113/jphysiol.2005.104315.
46. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14: 395-403, 2004.
47. Wong TS, Booth FW. Skeletal muscle enlargement with weight-lifting exercise by rats. J Appl Physiol 65: 950-954, 1988.